Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed)
The summary for the Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed): The purpose of the Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) award is to support federally recognized American Indian/Alaska Native (AI/AN) Tribes, Tribal colleges and universities, Tribal health programs, or Tribal organizations(collectively, eligible Tribal entities) to establish Institutional Review Boards (IRBs) or enhance the capacity of existing Tribal IRBs.
Federal Grant Title: | Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-24-260 |
Type of Funding: | Grant |
CFDA Numbers: | 93.859 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | January 27th, 2027 |
Original Application Deadline: | January 27th, 2027 |
Posted Date: | August 12th, 2024 |
Creation Date: | August 12th, 2024 |
Archive Date: | March 4th, 2027 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | August 12th, 2024 |
- Applicants Eligible for this Grant
- Native American tribal governments (Federally recognized) - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/pa-files/PAR-24-260.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Pro...
- • Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Pro...
- • Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial N...
- • Bridges to the Doctorate Research Training Program (T32)
- • B-INSPIRE: Research on Behavioral Interventions that Promote Careers in the Biomedical Re...
- • Tools for Genetic and Genomic Studies in Emerging Model Organisms
- • Evolution of Infectious Diseases
- • Mbrs Support of Continuous Research Excellence (Score)
- More Grants from the National Institutes of Health
- • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
- • Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
- • Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Inc...
- • Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Tri...
- • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...